YANG ARVIN (Chief Medical Officer) sold 29.9% of their position (5.53K shares) of MERSANA THERAPEUTICS, INC. on the open market
Open‑market sale worth $37.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/2/2021ACC: 0001104659-21-145951
Officer· Chief Medical Officer
Since Nov 2020
-5.53K
Net shares
Net seller
$37.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
18.50K acquired · 24.03K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+18.50K
Price / share
—
Trade value
—
% of position
New position
11/30/2021
0.00→18.50K
Common Stock
Direct
Shares
−5.53K
Price / share
$6.81
Trade value
$37.64K
% of position
29.9%
12/1/2021
18.50K→12.97K
Total
Net shares
+12.97K
Net value
-$37.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/30/2021 | M · Option Exercise | +18.50K | — | — | New position | 0.00 | 18.50K |
| Common Stock Direct | 12/1/2021 | S · Sale | −5.53K | $6.81 | $37.64K | 29.9% | 18.50K | 12.97K |
| Total | +12.97K | -$37.64K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
18.50K shares
Shares
−18.50K
Strike price
Held after
18.50K
Exercisable
—
11/30/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock18.50K shares | 11/30/2021 | M · Option Exercise | −18.50K | — | 18.50K |